Michael Parr, PhD

Director of Formulation and Process Development at Evonik

Dr. Parr’s professional expertise includes drug delivery systems, formulation, viral vector design, GLP and GMP activities and clinical development. Dr. Parr holds a Ph.D. in Biochemistry and Molecular Biology from the University of British Columbia and completed post-doctoral studies at Harvard Medical School. He currently serves as part of the Evonik Health Care division, in the position of Director of Formulation and Process Development for the Vancouver site, responsible for leading multifunctional teams and ensuring the successful execution of a portfolio of complex customer-funded development programs as part of the Parenteral Drug Delivery Solutions business.